Approximately two years ago the Cardinal Health DSP Advisory Board was established as a way to allow our developing branded pharmaceutical suppliers to have a forum where they could connect and share their ideas with each other and Cardinal Health. Two years later, this platform is still in place with the goals of enhancing the manufacturer and wholesaler relationship, serving as an advocate for improvement, discussing program development opportunities/value added services, collaborating on healthcare industry issues/concerns, discussing best practices, and facilitating open and honest ideas/feedback. The most recent updates to our program involve inviting two of our active board members to serve as co-chairs to assist with developing topics and planning the quarterly meetings. The continued collaboration between Cardinal Health and our suppliers is appreciated by both sides and aims to continue fostering dialogue and assist in understanding what our smaller manufacturers value and require from their business partners. As this program continues to evolve we look forward to continuing to adapt and incorporate new opinions, ideas, and goals!
Cardinal Health will host the 2016 Business Partners Conference - our annual business meeting with our manufacturer partners - at the Hyatt Regency Columbus on October 11 - 12, 2016. This day and an half event provides you the opportunity to:
Below is a draft of our agenda, more information will be sent to you within the next few weeks regarding registration and information on scheduling meetings with your Cardinal Health contacts
We are looking forward to another very exciting and successful Business Partners Conference!
The next key milestones under the Drug Supply Chain Security Act (DSCSA) are fast approaching and Cardinal Health is committed to working with you to comply with the requirements of the law. As we prepare for unit level traceability and enhanced drug distribution security, Cardinal Health would like to share our expectations for how serialized data will be exchanged, so you can plan appropriately. We believe that an industry-wide, standards-based approach is necessary to maximize efficiency and insure interoperability. The full text of the DSCSA, including complete requirements for manufacturers, can be found on the FDA website.
As a reminder, key upcoming dates include:
Cardinal Health extends a sincere thank you for the continued partnership with our Medical manufacturers. We will continue to be highly committed to driving optimal EDI utilization. As part of our recent Supplier Scorecard rollout which went into effect April 1, 2016, we’ve adjusted our standard EDI compliance policy to create enhanced transparency and collaboration.
“Core 4” – Key transactions required from our medical national brand supplier partners.
Additionally, we are excited to expand our EDI transaction base to include EDI 845 / Price Authorization & Status Updates over the next quarter. Utilizing this HIDA endorsed tool allows suppliers to advise Cardinal Health of customer contract changes, and significantly reduces the risks tied to manually keyed updates. Aimed at achieving the “perfect order,” embracing EDI 845 usage will helps reduce credit & rebills, chargeback discrepancies and invoice deductions due to pricing variances. A pilot project is underway to assist suppliers that are unable to send EDI 845 directly to Cardinal Health, with the assistance of SPS Commerce.